Clinical Trials Directory

Trials / Completed

CompletedNCT01240265

Vitamin D Supplementation in Breastfeeding Women

Maternal Oral Vitamin D Supplementation Via Daily or Monthly Regimens and the Effect on Levels of Vitamin D in Human Milk and Infant Serum

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
1 Month – 50 Years
Healthy volunteers
Accepted

Summary

Adequate vitamin D is essential for proper infant growth and development. However, human milk is low in vitamin D, and most infants do not receive recommended supplementation. Our aim is to assess the feasibility of providing adequate vitamin D to breastfed infants through maternal vitamin D supplementation. Forty non-pregnant, lactating women at least 18 years of age with exclusively breastfed infants between the ages of 1 and 6 months will be randomized to receive oral vitamin D as either 5,000 IU daily for 28 days or 150,000 IU as a single dose. Maternal serum calcium, phosphorus, vitamin D and 25(OH)D; maternal urinary calcium; maternal milk vitamin D and 25(OH)D will be measured on days 0, 1, 3, 7, 14, and 28 of the study; and infant serum vitamin D and 25(OH)D will be measured on days 0 and 28.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin D3150,000 IU orally given once
DIETARY_SUPPLEMENTVitamin D35000 IU given orally daily for 28 days

Timeline

Start date
2010-12-01
Primary completion
2011-08-01
Completion
2011-08-01
First posted
2010-11-15
Last updated
2013-04-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01240265. Inclusion in this directory is not an endorsement.